stockrow
Friday 6 November 2026
Export INSP’s income statement to Excel — free account
Inspire Medical Systems, Inc.
INSP Healthcare Medical Devices
Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.
- Revenue
- −7.93%
- EPS
- −348.0%
- Free cash flow
- −33.1%
Quarter to September 2026, against a year earlier
63.84
2.69
−4.04%
Follow INSP
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 5 | 5 | 6 | 6 | 7 | 6 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 103.56 | 18.37 |
Altman Z-Score |
— | — | 10.26 | 25.03 | 56.83 | 56.93 | 62.24 | 35.22 | 29.33 | 14.49 |
P/S ratio |
0.97 | 0.97 | 12.18 | 21.53 | 42.50 | 26.87 | 17.41 | 8.81 | 6.87 | 2.97 |
Altman Z″-Score (non-manufacturers) |
— | (16.05) | 7.86 | 4.58 | 6.41 | 4.70 | 10.57 | 8.70 | 9.63 | 9.88 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,871.77 | 5,375.12 | 60.55 | 34.52 |
Beneish M-Score |
— | — | (1.58) | (1.85) | (2.15) | (1.49) | (2.25) | (0.87) | (2.39) | (1.88) |
P/Operating CF |
(5.01) | (5.01) | (237.93) | (290.74) | (1,193.22) | 8,545.13 | 368.57 | 318.77 | 79.76 | 51.62 |
P/B ratio |
0.00 | 0.00 | 3.76 | 12.63 | 21.35 | 27.38 | 14.32 | 9.61 | 8.00 | 3.47 |
Price to Tangible BV |
0.00 | 0.00 | 3.76 | 12.63 | 21.35 | 27.38 | 14.32 | 9.61 | 8.00 | 3.47 |
EV/Sales |
1.14 | 1.14 | 8.95 | 20.01 | 40.69 | 26.02 | 16.33 | 8.09 | 6.33 | 2.64 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150.46 | 38.86 |
EV/Operating CF |
(2.26) | (2.26) | (24.22) | (49.98) | (88.50) | (301.88) | 575.70 | 204.99 | 39.02 | 20.60 |
EV/FCF |
(2.24) | (2.24) | (23.90) | (46.13) | (84.59) | (245.03) | 2,693.19 | 4,935.10 | 55.77 | 30.71 |
Quick Ratio |
1.20 | 2.80 | 17.47 | 9.65 | 12.52 | 6.02 | 8.38 | 7.05 | 6.09 | 4.46 |
Current Ratio |
1.68 | 3.37 | 17.86 | 10.12 | 13.02 | 6.50 | 8.66 | 7.60 | 7.13 | 6.08 |
Net Debt/EBITDA |
(0.34) | (0.02) | 8.14 | 3.56 | 3.79 | 5.14 | 9.87 | 11.54 | (13.19) | (4.97) |
Debt/Assets |
0.00% | 65.60% | 12.46% | 13.53% | 8.80% | 5.35% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 12.40 | 0.15 | 0.18 | 0.11 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.31 | 2.28 | 0.45 | 0.43 | 0.50 | 0.81 | 0.95 | 1.01 | 1.08 | 1.06 |
Operating CF/Net income |
0.97 | 0.90 | 0.86 | 0.99 | 0.93 | 0.48 | (0.26) | (1.17) | 2.43 | 0.80 |
Capex/Depreciation |
(1.08) | (0.69) | (0.80) | 12.45 | (2.92) | (3.79) | (4.91) | (62.68) | 16.94 | (3.48) |
Interest Coverage |
(13.24) | (9.13) | (6.17) | (16.47) | (26.55) | (18.73) | (28.38) | — | 1,640.14 | 371.93 |
| 16.96% | 16.03% | (94.45%) | (21.88%) | (30.96%) | (18.33%) | (12.38%) | (3.96%) | 8.48% | 19.77% | |
| (147.69%) | (139.58%) | (19.39%) | (17.44%) | (24.74%) | (14.59%) | (10.44%) | (3.41%) | 7.21% | 16.95% | |
ROIC |
(189.31%) | (608.39%) | (1,781.29%) | (146.46%) | (174.51%) | (81.98%) | (66.70%) | (22.44%) | 9.24% | 6.73% |
Return on Tangible Assets |
(318.02%) | (97.59%) | (11.55%) | (21.20%) | (22.48%) | (17.84%) | (9.23%) | (3.81%) | 8.71% | 24.84% |
Average Days of Receivables |
46.46 | 49.29 | 48.10 | 58.41 | 79.29 | 53.45 | 54.79 | 52.51 | 42.31 | 47.90 |
Research and Development Expense of Revenue |
43.17% | 21.68% | 14.60% | 15.65% | 22.61% | 16.00% | 16.83% | 18.65% | 14.22% | 11.31% |
Selling, General and Administrative Expense of Revenue |
138.09% | 113.27% | 105.80% | 110.26% | 110.83% | 86.81% | 78.63% | 72.34% | 65.97% | 68.49% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.51% | 0.85% | 2.41% | 7.55% | 11.11% | 11.22% | 12.74% | 13.20% | 14.45% | 14.28% |
Graham Net Nets |
(0.18) | (0.18) | 0.26 | 0.07 | 0.04 | 0.03 | 0.06 | 0.09 | 0.09 | 0.17 |
Graham Number |
0.00 | 183.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.55 | 54.81 |
Earnings Yield |
(64.16%) | (64.16%) | (14.01%) | (1.87%) | (1.18%) | (0.67%) | (0.64%) | (0.39%) | 0.97% | 5.44% |
Free Cash Flow Yield |
(53.07%) | (53.07%) | (3.08%) | (2.01%) | (1.13%) | (0.40%) | 0.03% | 0.02% | 1.65% | 2.90% |
Revenue per Share |
14.99 | 24.27 | 3.47 | 3.45 | 4.43 | 8.56 | 14.53 | 21.32 | 26.97 | 31.05 |
Operating CF per Share |
(16.38) | (13.42) | (1.28) | (1.38) | (2.03) | (0.74) | 0.41 | 0.84 | 4.38 | 3.98 |
Capex per Share |
(0.28) | (0.35) | (0.02) | (0.12) | (0.09) | (0.17) | (0.32) | (0.81) | (1.31) | (1.31) |
Free Cash Flow per Share |
(16.66) | (13.77) | (1.30) | (1.49) | (2.13) | (0.91) | 0.09 | 0.03 | 3.06 | 2.67 |
Cash per Share |
6.10 | 13.72 | 12.91 | 6.28 | 8.99 | 7.87 | 16.08 | 15.71 | 14.97 | 10.50 |
Shareholders Equity per Share |
0.00 | 1.13 | 11.25 | 5.87 | 8.81 | 8.40 | 17.67 | 19.54 | 23.17 | 26.60 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 1.13 | 11.25 | 5.87 | 8.81 | 8.40 | 17.67 | 19.54 | 23.17 | 26.60 |
Free Cash Flow |
(18.25) | (16.20) | (18.94) | (35.58) | (55.50) | (24.79) | 2.47 | 1.02 | 91.12 | 78.48 |
Working Capital |
4.96 | 16.95 | 188.12 | 153.78 | 249.14 | 227.23 | 468.85 | 515.63 | 542.31 | 487.60 |
Capital Expenditures |
(0.31) | (0.41) | (0.25) | (2.74) | (2.45) | (4.67) | (9.10) | (23.63) | (39.12) | (38.50) |
Net Current Asset Value |
12.25 | 0.33 | 163.20 | 129.22 | 218.43 | 202.50 | 461.16 | 489.44 | 512.12 | 457.50 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 140.84 | 47.30 |
Capex to Sales |
0.02 | 0.01 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.04 | 0.05 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 152.91 | 53.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.33 | 0.60 | 0.39 | (0.07) | 0.16 | 0.15 | 0.11 | 0.01 | (0.03) | 0.11 |
Cash ROIC |
(95.75%) | (47.75%) | (5.02%) | (11.34%) | (11.35%) | (5.40%) | 0.26% | 0.10% | 8.03% | 7.20% |
Accounts Receivable Turnover |
5.52 | 9.60 | 9.61 | 8.29 | 6.04 | 7.88 | 8.55 | 8.27 | 8.78 | 8.57 |
Accounts Payable Turnover |
1.87 | 2.89 | 3.13 | 3.46 | 3.02 | 3.53 | 3.43 | 2.94 | 3.17 | 3.54 |
Inventory Turnover |
1.11 | 1.71 | 3.17 | 3.21 | 2.46 | 2.59 | 4.54 | 4.22 | 2.16 | 1.18 |
Average Days of Payables |
109.64 | 181.83 | 124.46 | 119.29 | 149.31 | 127.94 | 148.21 | 146.79 | 114.82 | 100.18 |
Days of Inventory on Hand |
313.59 | 222.59 | 96.80 | 156.08 | 175.61 | 188.99 | 65.62 | 128.07 | 237.78 | 398.06 |
Average Receivables |
2.97 | 2.97 | 5.26 | 9.90 | 19.10 | 29.62 | 47.70 | 75.56 | 91.48 | 106.38 |
Average Payables |
2.09 | 2.09 | 3.21 | 3.94 | 5.83 | 9.44 | 19.26 | 32.84 | 38.76 | 37.63 |
Average Inventory |
3.51 | 3.51 | 3.17 | 4.25 | 7.16 | 12.86 | 14.56 | 22.89 | 57.00 | 112.71 |
Average Assets |
12.55 | 12.55 | 112.59 | 190.67 | 231.22 | 288.14 | 429.98 | 620.84 | 742.60 | 857.85 |
Average Common Equity |
(109.26) | (109.26) | 23.11 | 151.92 | 184.79 | 229.40 | 362.53 | 534.26 | 631.10 | 735.43 |
Columns are period end dates · fundamentals updated 5 Nov 2026